HassanMYaishMD
Hematology • Salt Lake City, UTHematologic Oncology
Professor, Pediatrics, University of Utah School of Medicine
Dr. Yaish is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Mario Capecchi Dr Ste 1400
Salt Lake City, UT 84113Phone+1 801-662-4700
Education & Training
Corewell Health East Beaumont (Royal Oak)Residency, Pediatrics, 1970 - 1971- Corewell Health East Beaumont (Royal Oak)Residency, Pathology-Anatomic and Clinical, 1969 - 1970
- Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1968 - 1969
Damascus University Faculty of MedicineClass of 1963
Certifications & Licensure
MI State Medical License 1973 - 2027
UT State Medical License 2003 - 2022
FL State Medical License 2003 - 2021
IN State Medical License 2007 - 2011
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 3 citationsReal-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand DiseaseMichelle Sholzberg, Kate Khair, Hassan M. Yaish, George M. Rodgers, Maria Sol Cruz
TH Open. 2021-07-01 - 11 citationsPyruvate kinase deficiency in children.Satheesh Chonat, Stefan W. Eber, Susanne Holzhauer, Nina Kollmar, D. Holmes Morton
Pediatric Blood & Cancer. 2021-06-14 - 21 citationsComorbidities and complications in adults with pyruvate kinase deficiency.Audra N. Boscoe, Yan Yan, Elizabeth Hedgeman, Eduard J. van Beers, Hanny Al-Samkari
European Journal of Haematology. 2021-01-24
Abstracts/Posters
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencyHassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Characterization of the Severe Phenotype of Pyruvate Kinase DeficiencyHassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK StudyHassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
